GlassScriptPhysician profile
Siva Arunasalam
NPI 1609806041
$37,529.02
in general payments reported to CMS, 2019-2025
59 companies · $2,944 in 2025
The $2,944 reported for 2025 was more than what 88% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $3,243 · 2021: $3,874 · 2022: $11K · 2023: $1,867 · 2024: $3,454 · 2025: $2,944.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,255 · Education: $10.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,254.75 |
| Education | $10.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $9,641.58 | 2021-2025 | Onyx Frontier, Symplicity G3, Azure Xt Dr Mri Surescan |
| Novartis Pharmaceuticals Corporation | $6,292.46 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $4,182.98 | 2019-2025 | |
| Shockwave Medical, INC | $3,821.51 | 2020-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Cathworks, INC. | $2,140.00 | 2021 | |
| Medtronic Vascular, INC. | $1,778.67 | 2020 | |
| Merck Sharp & Dohme LLC | $1,280.77 | 2021-2025 | Verquvo, Winrevair, Belsomra |
| Biotronik INC. | $981.61 | 2019-2024 | Acticor 7 Vr-T Dx, Amvia Edge |
| Janssen Pharmaceuticals, INC | $708.70 | 2019-2024 | Xarelto |
| Amarin Pharma, INC. | $673.31 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $590.26 | 2019-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $486.70 | 2019-2024 | Farxiga, Airsupra |
| Pfizer INC. | $482.46 | 2019-2025 | |
| Novo Nordisk INC | $389.49 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Inari Medical, INC. | $323.14 | 2021-2022 |
Show all 59 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scpharmaceuticals INC. | $310.65 | 2023-2024 | |
| Heartflow, INC. | $305.31 | 2021-2024 | |
| Boston Scientific Corporation | $270.95 | 2020-2024 | |
| Cardiovascular Systems INC. | $248.25 | 2019-2023 | Diamondback Coronary |
| Baxter Healthcare | $209.55 | 2022-2025 | Hillrom - Volara System, Hillrom - Monarch Airway Clearance System |
| E.R. Squibb & Sons, L.L.C. | $207.78 | 2022-2025 | Eliquis, Camzyos |
| Takeda Pharmaceuticals U.S.A., INC. | $146.17 | 2019-2022 | |
| Abbott Laboratories | $135.45 | 2021-2024 | Diamondback Coronary |
| Welch Allyn | $134.69 | 2021 | |
| Elutia, INC. | $133.47 | 2022 | |
| Sanofi-Aventis U.S. LLC | $109.87 | 2019-2024 | |
| United Therapeutics Corporation | $109.17 | 2019-2025 | Tyvaso |
| Abiomed | $107.11 | 2020-2025 | |
| Vital Connect, INC | $102.45 | 2022 | |
| Abbvie INC. | $93.23 | 2020-2024 | Ubrelvy |
| Allergan, INC. | $85.14 | 2019-2020 | |
| Actelion Pharmaceuticals US, INC. | $84.14 | 2019-2025 | Uptravi, Opsumit, Opsynvi |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $80.06 | 2020-2023 | Lifevest |
| Edwards Lifesciences Corporation | $79.75 | 2021-2024 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Esperion Therapeutics, INC. | $66.20 | 2021 | |
| Amgen INC. | $65.27 | 2019-2022 | |
| Astellas Pharma US INC | $63.10 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $58.88 | 2023 | Inpefa |
| Kestra Medical Technology Services, INC. | $57.28 | 2022-2024 | Assure Wcd |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $55.81 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $50.93 | 2020-2021 | |
| W. L. Gore & Associates, INC. | $40.18 | 2020-2023 | C3 Delivery System |
| Lilly USA, LLC | $39.87 | 2020-2021 | |
| Mylan Specialty L.P. | $28.98 | 2019-2023 | Yupelri |
| Philips North America LLC | $28.84 | 2019-2024 | (8874) Incourage |
| Eisai INC. | $25.11 | 2020-2021 | |
| Bridgebio Pharma, INC. | $20.57 | 2025 | Attruby |
| Cordis US Corp. | $20.25 | 2022 | |
| Sunovion Pharmaceuticals INC. | $18.78 | 2019 | |
| Aegerion Pharmaceuticals, INC. | $18.58 | 2019 | |
| Vifor Pharma, INC. | $18.03 | 2019 | |
| Kiniksa Pharmaceuticals, LTD. | $17.61 | 2023 | Arcalyst |
| Arbor Pharmaceuticals, INC. | $17.30 | 2022 | |
| Vivus LLC | $16.19 | 2024 | Pancreaze |
| Biohaven Pharmaceutical Holding Company LTD. | $16.18 | 2022 | |
| Alnylam Pharmaceuticals INC. | $15.99 | 2020 | |
| Glaxosmithkline, LLC. | $15.20 | 2025 | Arexvy, Shingrix |
| Kiniksa Pharmaceuticals International, Plc | $13.87 | 2024 | Arcalyst |
| Smith+Nephew, INC. | $13.19 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Siva Arunasalam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.